Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-06-000257
Filing Date
2006-03-22
Accepted
2006-03-22 17:29:33
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a18081e10vk.htm 10-K 892104
2 EXHIBIT 10.23 a18081exv10w23.htm EX-10.23 7246
3 EXHIBIT 23.1 a18081exv23w1.htm EX-23.1 1180
4 EXHIBIT 31.1 a18081exv31w1.htm EX-31.1 8401
5 EXHIBIT 31.2 a18081exv31w2.htm EX-31.2 8597
6 EXHIBIT 32.1 a18081exv32w1.htm EX-32.1 8712
7 GRAPHIC a18081x1256401.gif GRAPHIC 6044
  Complete submission text file 0000936392-06-000257.txt   936142
Mailing Address 12750 HIGH BLUFF DRIVE, SUITE 310 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE, SUITE 310 SAN DIEGO CA 92130 (858) 509-3670
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51665 | Film No.: 06704531
SIC: 2834 Pharmaceutical Preparations